Q32 Bio Inc.

Historical 13F Holders

Symbol
QTTB
CUSIP
746964105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 746964105 since 12/18/2024, largest first.

Filer % of Class Filed
Orbimed Advisors LLC 13D/A
13.9% 7/20/2026
Event 7/16/2026
Biotechnology Value Fund L P 13G/A
10.0% 11/16/2026
Event 9/30/2026
RA Capital Management, L.P. 13G/A
9.9% 11/16/2026
Event 9/30/2026
Boxer Capital Management, LLC 13G/A
7.9% 11/6/2026
Event 9/30/2026
Bank of America Corp /DE/ 13G 7.4% 10/28/2026
Event 9/30/2026
Frazier Life Sciences Public Fund, L.P. 13G
5.9% 10/9/2026
Event 10/2/2026
Price T Rowe Associates Inc /MD/ 13G 5.0% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Point72 Asset Management, L.P. 13G/A
4.95% 8/14/2026
Event 6/30/2026
Sirenia Capital Management LP 13G/A
4.2% 11/16/2026
Event 6/30/2026
Carlyle Group Inc. 13G/A
4.1% 7/6/2026
Event 6/30/2026
Opaleye Management Inc. 13G/A
3.8% 11/6/2026
Event 9/30/2026
Atlas Venture Fund X, L.P. 13D/A
3.6% 5/28/2026
Event 5/26/2026
Pfizer Inc 13G/A 2.3% 2/13/2026
Event 12/31/2024
Bristol Myers Squibb Co 13G/A 1.6% 2/14/2025
Event 12/31/2024
Sio Capital Management, LLC 13G 0% 4/8/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 105 31.5 M $262M
2026 Q2 72 22.2 M $283M
2026 Q1 53 9.43 M $60.6M
2025 Q4 52 8.04 M $26.7M
2025 Q3 53 8.43 M $16.6M
2025 Q2 63 8.98 M $13.4M
2025 Q1 74 9.41 M $15.5M
2024 Q4 94 11.0 M $37.8M
2024 Q3 74 9.11 M $406M
2024 Q2 55 8.07 M $144M
2024 Q1 39 7.43 M $126M